Leap Therapeutics’ stock skyrocketed 300% after revealing a $50 million Zcash purchase, backed by Winklevoss Capital. The former biotech company is rebranding as Cypherpunk Technologies, shifting focus to digital asset treasuries.
Zcash’s value surged 12% to $523 following the buy. Executives said the privacy-focused cryptocurrency offers protection against surveillance-driven finance. The move mirrors Michael Saylor’s corporate crypto strategy, signaling renewed investor interest in digital assets despite a cooling treasury market.
You need to login in order to Like
Leave a comment